Transcriptome and Functional Profile of Cardiac Myocytes Is Influenced by Biological Sex

Circulation: Cardiovascular Genetics

Volumn 10, Issue 5, 2017, Pages

  Trexler, Christa L ^a   Odell, Aaron T ^a   Jeong, Mark Y ^b   Dowell, Robin D ^a   Leinwand, Leslie A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

cardiovascular diseases; gene expression; myocytes, cardiac; rats; sequence analysis, RNA; sex differences

Indexed keywords

ANDROGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOCHROME C OXIDASE; ESTROGEN; TRANSCRIPTOME;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CARDIOVASCULAR DISEASE; CELL FUNCTION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENDER; GENE EXPRESSION; GENE MAPPING; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; IN VIVO STUDY; MALE; MUSCLE FIBRIL; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; RNA SEQUENCE; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 85032983935     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.117.001770     Document Type: Article

References (41)

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131:e29-e322. doi: 10.1161/CIR.0000000000000152.
2. Miller VM, Best PJ. Implications for reproductive medicine: sex differences in cardiovascular disease. Sex Reprod Menopause. 2011;9:21-28.
3. Consideration of sex as a biological variable in NIH-funded research. 2015.
4. Clayton JA, Collins FS. Policy: NIH to balance sex in cell and animal studies. Nature. 2014;509:282-283.
5. Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov. 2006;5:425-438. doi: 10.1038/nrd2032.
6. Prabhavathi K, Selvi KT, Poornima KN, Sarvanan A. Role of biological sex in normal cardiac function and in its disease outcome - a review. J Clin Diagn Res. 2014;8:BE01-BE04. doi: 10.7860/JCDR/2014/9635.4771.
7. Chung AK, Das SR, Leonard D, Peshock RM, Kazi F, Abdullah SM, et al. Women have higher left ventricular ejection fractions than men independent of differences in left ventricular volume: the Dallas Heart Study. Circulation. 2006;113:1597-1604. doi: 10.1161/CIRCULATIONAHA.105.574400.
8. Haines CD, Harvey PA, Leinwand LA. Estrogens mediate cardiac hypertrophy in a stimulus-dependent manner. Endocrinology. 2012;153:4480-4490. doi: 10.1210/en.2012-1353.
9. Litwin SE, Katz SE, Litwin CM, Morgan JP, Douglas PS. Gender differences in postinfarction left ventricular remodeling. Cardiology. 1999;91:173-183. doi: 6906.
10. Grandy SA, Howlett SE. Cardiac excitation-contraction coupling is altered in myocytes from aged male mice but not in cells from aged female mice. Am J Physiol Heart Circ Physiol. 2006;291:H2362-H2370. doi: 10.1152/ajpheart.00070.2006.
11. Howlett SE. Age-associated changes in excitation-contraction coupling are more prominent in ventricular myocytes from male rats than in myocytes from female rats. Am J Physiol Heart Circ Physiol. 2010;298:H659-H670. doi: 10.1152/ajpheart.00214.2009.
12. Parks RJ, Howlett SE. Sex differences in mechanisms of cardiac excitation-contraction coupling. Pflugers Arch. 2013;465:747-763. doi: 10.1007/s00424-013-1233-0.
13. Regitz-Zagrosek V, Kararigas G. Mechanistic pathways of sex differences in cardiovascular disease. Physiol Rev. 2017;97:1-37. doi: 10.1152/physrev.00021.2015.
14. Blenck CL, Harvey PA, Reckelhoff JF, Leinwand LA. The importance of biological sex and estrogen in rodent models of cardiovascular health and disease. Circ Res. 2016;118:1294-1312. doi: 10.1161/CIRCRESAHA.116.307509.
15. Lenzen MJ, Rosengren A, Scholte op Reimer WJ, Follath F, Boersma E, Simoons ML, et al. Management of patients with heart failure in clinical practice: differences between men and women. Heart. 2008;94:e10. doi: 10.1136/hrt.2006.099523.
16. Isensee J, Witt H, Pregla R, Hetzer R, Regitz-Zagrosek V, Noppinger PR. Sexually dimorphic gene expression in the heart of mice and men. J Mol Med (Berl). 2008;86:61-74. doi: 10.1007/s00109-007-0240-z.
17. Fermin DR, Barac A, Lee S, Polster SP, Hannenhalli S, Bergemann TL, et al. Sex and age dimorphism of myocardial gene expression in nonischemic human heart failure. Circ Cardiovasc Genet. 2008;1:117-125. doi: 10.1161/CIRCGENETICS.108.802652.
18. Yu Y, Fuscoe JC, Zhao C, Guo C, Jia M, Qing T, et al. A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages. Nat Commun. 2014;5:3230. doi: 10.1038/ncomms4230.
19. Haines CD, Harvey PA, Luczak ED, Barthel KK, Konhilas JP, Watson PA, et al. Estrogenic compounds are not always cardioprotective and can be lethal in males with genetic heart disease. Endocrinology. 2012;153:4470-4479. doi: 10.1210/en.2012-1391.
20. Vijay V, Han T, Moland CL, Kwekel JC, Fuscoe JC, Desai VG. Sexual dimorphism in the expression of mitochondria-related genes in rat heart at different ages. PLoS One. 2015;10:e0117047. doi: 10.1371/journal.pone.0117047.
21. Murphy E, Amanakis G, Fillmore N, Parks RJ, Sun J. Sex differences in metabolic cardiomyopathy. Cardiovasc Res. 2017. doi: 10.1093/cvr/cvx008.
22. Pugach EK, Richmond PA, Azofeifa JG, Dowell RD, Leinwand LA. Prolonged Cre expression driven by the α-myosin heavy chain promoter can be cardiotoxic. J Mol Cell Cardiol. 2015;86:54-61. doi: 10.1016/j. yjmcc.2015.06.019.
23. Tesi C, Colomo F, Nencini S, Piroddi N, Poggesi C. The effect of inorganic phosphate on force generation in single myofibrils from rabbit skeletal muscle. Biophys J. 2000;78:3081-3092. doi: 10.1016/S0006-3495(00)76845-7.
24. Colomo F, Nencini S, Piroddi N, Poggesi C, Tesi C. Calcium dependence of the apparent rate of force generation in single striated muscle myofibrils activated by rapid solution changes. Adv Exp Med Biol. 1998;453:373-381; discussion 381.
25. Demos-Davies KM, Ferguson BS, Cavasin MA, Mahaffey JH, Williams SM, Spiltoir JI, et al. HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling. Am J Physiol Heart Circ Physiol. 2014;307:H252-H258. doi: 10.1152/ajpheart.00149.2014.
26. Tesi C, Colomo F, Nencini S, Piroddi N, Poggesi C. Modulation by substrate concentration of maximal shortening velocity and isometric force in single myofibrils from frog and rabbit fast skeletal muscle. J Physiol. 1999;516 (pt 3):847-853.
27. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44-57. doi: 10.1038/nprot.2008.211.
28. Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11:R106. doi: 10.1186/gb-2010-11-10-r106.
29. Curl CL, Wendt IR, Kotsanas G. Effects of gender on intracellular. Pflugers Arch. 2001;441:709-716.
30. den Ruijter H, Pasterkamp G, Rutten FH, Lam CS, Chi C, Tan KH, et al. Heart failure with preserved ejection fraction in women: the Dutch Queen of Hearts program. Neth Heart J. 2015;23:89-93. doi: 10.1007/s12471-014-0613-1.
31. Pugach EK, Blenck CL, Dragavon JM, Langer SJ, Leinwand LA. Estrogen receptor profiling and activity in cardiac myocytes. Mol Cell Endocrinol. 2016;431:62-70. doi: 10.1016/j.mce.2016.05.004.
32. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev. 2007;87:905-931. doi: 10.1152/physrev.00026.2006.
33. Bennett NC, Gardiner RA, Hooper JD, Johnson DW, Gobe GC. Molecular cell biology of androgen receptor signalling. Int J Biochem Cell Biol. 2010;42:813-827. doi: 10.1016/j.biocel.2009.11.013.
34. Yang X, Schadt EE, Wang S, Wang H, Arnold AP, Ingram-Drake L, et al. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res. 2006;16:995-1004. doi: 10.1101/gr.5217506.
35. Lindholm ME, Huss M, Solnestam BW, Kjellqvist S, Lundeberg J, Sundberg CJ. The human skeletal muscle transcriptome: sex differences, alternative splicing, and tissue homogeneity assessed with RNA sequencing. FASEB J. 2014;28:4571-4581. doi: 10.1096/fj.14-255000.
36. Tsuji M, Kawasaki T, Matsuda T, Arai T, Gojo S, Takeuchi JK. Sexual dimorphisms of mRNA and miRNA in human/murine heart disease. PLoS One. 2017;12:e0177988. doi: 10.1371/journal.pone.0177988.
37. Israeli-Rosenberg S, Manso AM, Okada H, Ross RS. Integrins and integrin-associated proteins in the cardiac myocyte. Circ Res. 2014;114:572-586. doi: 10.1161/CIRCRESAHA.114.301275.
38. Stewart JA Jr, Cashatt DO, Borck AC, Brown JE, Carver WE. 17beta-estradiol modulation of angiotensin II-stimulated response in cardiac fibroblasts. J Mol Cell Cardiol. 2006;41:97-107. doi: 10.1016/j.yjmcc.2006.04.019.
39. Walker JS, Walker LA, Margulies K, Buttrick P, de Tombe P. Protein kinase A changes calcium sensitivity but not crossbridge kinetics in human cardiac myofibrils. Am J Physiol Heart Circ Physiol. 2011;301:H138-H146. doi: 10.1152/ajpheart.00838.2010.
40. Rao V, Cheng Y, Lindert S, Wang D, Oxenford L, McCulloch AD, et al. PKA phosphorylation of cardiac troponin I modulates activation and relaxation kinetics of ventricular myofibrils. Biophys J. 2014;107:1196-1204. doi: 10.1016/j.bpj.2014.07.027.
41. Somekawa S, Fukuhara S, Nakaoka Y, Fujita H, Saito Y, Mochizuki N. Enhanced functional gap junction neoformation by protein kinase A-dependent and Epac-dependent signals downstream of cAMP in cardiac myocytes. Circ Res. 2005;97:655-662. doi: 10.1161/01. RES.0000183880.49270.f9.